Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

INTEGRAL MOLECULAR INC

UEI: DY9KSWE8EJB8CAGE: 3PJG4

INTEGRAL MOLECULAR INC is a federal contractor, registered under UEI DY9KSWE8EJB8 and CAGE code 3PJG4. It has been awarded $62,536,640 in federal contracts. Primary work spans Unknown NAICS, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and Research and Development in Biotechnology. Top awarding agencies include Department Of Health And Human Services, Department Of Health And Human Services (hhs), and Other agencies (2 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

DY9KSWE8EJB8

CAGE Code

3PJG4

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

541714Research and Development in Biotechnology (except Nanobiotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Integral Molecular Inc. specializes in the design and development of advanced reagents and analytical tools for immunological research, with a focus on antibody discovery, epitope characterization, and diagnostic assay development for underrepresented mammalian and non-mammalian models. The company ...

Integral Molecular Inc. specializes in the design and development of advanced reagents and analytical tools for immunological research, with a focus on antibody discovery, epitope characterization, and diagnostic assay development for underrepresented mammalian and non-mammalian models. The company leverages cutting-edge molecular biology and structural immunology techniques to identify and validate B cell epitopes against high-consequence viral pathogens such as RVFV, CCHFV, and EV-D68, enabling enhanced serological surveillance and vaccine development. Their technical expertise spans protein engineering, immunoassay optimization, and cross-species antigen validation, with a distinct specialization in overcoming limitations of traditional model systems through bespoke reagent development. This capability positions them as a niche provider of critical reagents for global health and biosurveillance initiatives. The company maintains a strong relationship with the Department of Health and Human Services, delivering mission-critical research and development services focused on infectious disease diagnostics and immunological toolkits. They also support the Department of State through the provision of specialized laboratory instrumentation and supplies, indicating engagement in international biosafety and capacity-building efforts. Integral Molecular Inc. operates primarily under NAICS 541714 and 541715, focusing on biotechnology research and life sciences R&D outside of nanotechnology. Their market positioning centers on solving complex challenges in immunodiagnostics, particularly where conventional reagents fail due to species-specific antigenic divergence. This vertical specialization makes them a trusted partner for agencies requiring tailored solutions for emerging pathogen threats. As a small business structured as a 2L entity based in Philadelphia, PA, Integral Molecular Inc. operates without federal certifications but maintains a focused, high-impact presence in the federal life sciences R&D market, delivering precision tools that bridge the gap between basic research and operational biosurveillance.

Key Performance Metrics

Awards Count

58

All time

Active

6

Currently performing

Completed

52

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by Agency Over Time
Awards by Place of Performance

Compete with INTEGRAL MOLECULAR INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for INTEGRAL MOLECULAR INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in INTEGRAL MOLECULAR INC's top NAICS codes and agencies

NAICS: 541714
New
Federal
RFI Alzheimer’s Research Program (AZRP) Public
Solicitation # HT9427RFI2027AZRP
The Defense Health Agency, through the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027AZRP to gather strategic feedback for the fiscal year 2027 Alzheimer’s Research Program. The primary objective is to identify research focus areas and funding opportunities aimed at mitigating the impact of Alzheimer's and related dementias, specifically those associated with traumatic brain injury, military service, and diverse risks. The program seeks to improve the quality of life for Service Members, Veterans, and their families by funding solution-oriented research, including the development of digital and blood-based biomarkers for early diagnosis and the creation of precision prevention strategies. This action is strictly for information and planning purposes and does not constitute a formal solicitation, request for proposals, or request for quotations. No contracts will be awarded based on this announcement, and FY27 funds have not yet been appropriated. Interested parties from academia, industry, non-profit organizations, and federal agencies are invited to provide feedback via Survey Monkey by December 4, 2026. Respondents are cautioned not to submit proprietary or sensitive information through the survey portal as it cannot be protected. The effort is categorized under NAICS code 541714 and is managed by the Department of Defense in Fort Detrick, Maryland.
Defense Health Agency

POSTED

about 21 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Federal
Traumatic Brain Injury and Psychological Health Research Program Public Request for Information
Solicitation # HT9427RFI2027TBIPHRP
The Defense Health Agency, under the Department of Defense and the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027TBIPHRP. This action is strictly for strategic planning and is not a formal solicitation, request for proposals, or request for quotations. The primary objective is to gather feedback from academia, industry, non-profit organizations, and the public to inform the research focus areas and funding opportunities for the fiscal year 2027 Traumatic Brain Injury and Psychological Health Research Program. The program aims to optimize the prevention, assessment, and treatment of psychological health conditions and traumatic brain injuries to benefit Service Members, Veterans, and the general public. Interested parties are asked to provide input on research gaps and funding priorities, specifically regarding the prevention, screening, diagnosis, and treatment of these conditions. Responses must be submitted via Survey Monkey by December 11, 2026. Because the government cannot protect proprietary or sensitive information submitted through the survey platform, such data should not be included. This inquiry does not commit the program to incorporating the feedback into future funding opportunities, and no contract will be awarded based on this specific announcement. All inquiries regarding this RFI should be directed to Patrick M. Younkins.
Defense Health Agency

POSTED

about 21 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
New
Federal
Atomically Precise Molecules (APM)
Solicitation # DARPA-PS-26-141
The Atomically Precise Molecules (APM) program, solicitation DARPA-PS-26-141, is a 36-month initiative by the DARPA Multi X Office seeking innovative synthesis techniques for programmable precision polymers (PPPs) and nonlinear optical (NLO) materials. The program aims to develop scalable materials with strictly controlled monomer sequences and compositions, culminating in a prototype NLO material integrated into a government-provided electro-optic modulator capable of achieving greater than 1THz modulation. The effort is structured in two phases, with Phase I lasting 12 months and focusing on synthesis capabilities. Research limited to inorganic materials or incremental improvements to existing state-of-the-art practices is specifically excluded. Awards will be issued as Other Transaction for Prototype Agreements, with payments processed through the Wide Area Workflow system based on a schedule of milestones. Proposals are due by December 18, 2026, via the Broad Agency Announcement Tool and must include technical, management, and pricing volumes. Eligibility is restricted to U.S. organizations, and all performers must comply with CMMC Level 2 self-certification and NIST SP 800-171 standards for safeguarding Controlled Unclassified Information. Evaluation will be based on technical approach, relevance to the DARPA mission, budget realism, and the capability to transition the technology to military or commercial sectors.
Defense Advanced Research Projects Agcy

POSTED

about 21 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 541715
New
Federal
Request for Proposal (RFP) - Resilient Missile Warning Tracking (RMWT) Low Earth Orbit (LEO) Ground Entry Points (GEPs)
Solicitation # FA240126R0003
The Space Development Agency is soliciting proposals under solicitation FA240126R0003 for the Resilient Missile Warning Tracking Low Earth Orbit Ground Entry Points effort. This acquisition is structured as an Indefinite Delivery Indefinite Quantity contract with a ceiling of 369 million dollars, covering the development, integration, test, operations, and maintenance of Tranche 3 Ground Entry Points at multiple globally dispersed locations. The scope of work encompasses civil engineering from detailed design through construction, the procurement and installation of communications shelters, antennas, optical terminals, and networking equipment, as well as the development of Ground Support Equipment and Auxiliary Development Units. The contract includes an ordering period from March 31, 2027, to September 30, 2031, with option periods extending through September 30, 2035. Award will be determined using a best value tradeoff process where technical, management, and past performance factors are combined and considered significantly more important than price. The technical evaluation focuses on the understanding of requirements, feasibility of approach, and scalability, while management is assessed based on project and schedule management, subcontractor oversight, and security handling. Proposals must be submitted in seven volumes via the DoD Secure Access File Exchange by 4:00 PM Eastern Time on November 23, 2026. Large business primes are required to meet a minimum quantitative requirement of 5 percent small business participation. The contract utilizes a mix of Firm Fixed Price for primary labor and materials and Cost Reimbursable arrangements for other direct costs and travel.
FA2401 Space Development Agency Sda

POSTED

about 21 hours ago

DEADLINE

in 26 days
View Details